Jinjing is a PhD candidate at the University Medical Center Groningen, with a background in health economic evaluation. Her research focuses on early cost-effectiveness analysis of AI-based technologies in the QoLEAD. Jinjing holds a European Master of Health Economic and Management. She completed her master’s thesis on the early cost-effectiveness analysis of whole genome sequencing at The Netherlands Cancer Institute. Previously, she worked in marketing for biotech investment and pharmaceutical companies.